Metraipolis › archive › dc_a10cb27fe0bf

BH3 Profiling Identifies Apoptotic Priming by SREBP-1/-2 Inhibition and Synergistic Anti-Glioblastoma Activity When Combined with ABT-263 In Vitro — Europe PMC PMID:42942857

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42942857
DOI
10.3390/pharmaceutics18101327
License (as archived)
solo-consultazione
Archived
2026-10-31T21:56:38.818Z
SHA-256 of the archived text
fecc7afabea7c9a05385cdb005bdda6ad73a8381ffd72f51120490d50bfa96ed
Stable URL of this page
https://metraipolis.com/documento/dc_a10cb27fe0bf

How to cite

BH3 Profiling Identifies Apoptotic Priming by SREBP-1/-2 Inhibition and Synergistic Anti-Glioblastoma Activity When Combined with ABT-263 In Vitro — Europe PMC PMID:42942857 — Europe PMC (en), https://europepmc.org/article/MED/42942857 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a10cb27fe0bf (Metraipolis archive dc_a10cb27fe0bf, sha256 fecc7afabea7c9a05385cdb005bdda6ad73a8381ffd72f51120490d50bfa96ed)
BibTeX
@misc{dca10cb27fe0bf,
  title = {BH3 Profiling Identifies Apoptotic Priming by SREBP-1/-2 Inhibition and Synergistic Anti-Glioblastoma Activity When Combined with ABT-263 In Vitro — Europe PMC PMID:42942857},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42942857},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a10cb27fe0bf; sha256 fecc7afabea7c9a05385cdb005bdda6ad73a8381ffd72f51120490d50bfa96ed},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42942857. Agents can read the archived copy with the MCP tool read_document.